Fertility and Sterility
Volume 91, Issue 2 , Pages 456-488 , February 2009

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

  • Ricardo Azziz, M.D., M.P.H.

      Affiliations

    • Cedars-Sinai Medical Center and The David Geffen School of Medicine at UCLA, Los Angeles, California (Task Force Chair)
    • ,
  • Enrico Carmina, M.D.

      Affiliations

    • University of Palermo, Palermo, Italy
    • Corresponding Author InformationReprint requests: Enrico Carmina, M.D., Department of Clinical Medicine, University of Palermo, via delle Croci 47, 90139 Palermo, Italy (FAX: +39-091-655-5995).
    • ,
  • Didier Dewailly, M.D.

      Affiliations

    • Lille University Hospital, Lille, France
    • ,
  • Evanthia Diamanti-Kandarakis, M.D.

      Affiliations

    • University of Athens Medical School, Athens, Greece
    • ,
  • Héctor F. Escobar-Morreale, M.D., Ph.D.

      Affiliations

    • Hospital Ramon y Cajal, Madrid, Spain
    • ,
  • Walter Futterweit, M.D.

      Affiliations

    • Mount Sinai School of Medicine, New York, New York
    • ,
  • Onno E. Janssen, M.D.

      Affiliations

    • University of Essen, Essen, Germany
    • ,
  • Richard S. Legro, M.D.

      Affiliations

    • Pennsylvania State University School of Medicine, Hershey, Pennsylvania
    • ,
  • Robert J. Norman, M.D.

      Affiliations

    • University of Adelaide, Adelaide, Australia
    • ,
  • Ann E. Taylor

      Affiliations

    • Novartis, Cambridge, Massachusetts
    • ,
  • Selma F. Witchel, M.D.

      Affiliations

    • Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • (Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society)

      Affiliations

    • Formerly the Androgen Excess Society.

Received 12 February 2008 ,Revised 19 June 2008 ,Accepted 23 June 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 R.A. is a consultant for drug development at Proctor & Gamble. E.C. has nothing to disclose. D.D. has nothing to disclose. E.D.-K. has nothing to declare. H.F.E.-M. has nothing to disclose. W.F. has nothing to disclose. O.E.J. has nothing to disclose. R.S.L. is a consultant for Glaxo Smith Kline, Ferring, Quat. Rx, Organon, Serono, and Solvay. R.J.N. has nothing to disclose. A.E.T. is an employee of Novartis. S.F.W. has nothing to disclose.

PII: S0015-0282(08)01392-7

doi: 10.1016/j.fertnstert.2008.06.035

Fertility and Sterility
Volume 91, Issue 2 , Pages 456-488 , February 2009

Article Tools

* Image Usage & Resolution